13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Research home > Beat Cancer Project search > Targeting microRNA-regulated tumour plasticity to improve prostate cancer outcomes

    Targeting microRNA-regulated tumour plasticity to improve prostate cancer outcomes

    Associate Professor Luke Selth
    • Donor Funding: $100,000
    • Cancer Type: Prostate
    • Cancer Stage: Treatment
    • Funded in: 2020
    • Associate Professor Luke Selth
      Flinders University

    Current therapies for metastatic prostate cancer, which kills >3000 Australian men each year, are not curative. We have found a new class of drugs, termed CDK9 inhibitors, to have great potential to treat prostate cancer. The purpose of this project is to test the effectiveness of CDK9 inhibitors in unique models of prostate cancer made from patient tumours, and additionally determine how these drugs work.



  • Apply for funding

    Apply for funding

    Find out more about applications for funding.

  • Cancer statistics

    Cancer statistics

    Access the latest cancer statistics for South Australia

  • Clinical trials

    Clinical trials

    Access the list of current clinical trials taking place in South Australia.